Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer
Open accessAbstract
The transcription factor NRF2 is a master regulator of the cellular antioxidant response, and it is often genetically activated in non-small-cell lung cancers (NSCLCs) by, for instance, mutations in the negative regulator KEAP1. While direct pharmacological inhibition of NRF2 has proven challenging, its aberrant activation rewires biochemical networks in cancer cells that may create special vulnerabilities. Here, we use chemical proteomics to map druggable proteins that are selectively expressed in KEAP1-mutant NSCLC cells. Principal among these is NR0B1, an atypical orphan nuclear receptor that we show engages in a multimeric protein complex to regulate the transcriptional output of KEAP1-mutant NSCLC cells. We further identify small molecules that covalently target a conserved cysteine within the NR0B1 protein interaction domain, and we demonstrate that these compounds disrupt NR0B1 complexes and impair the anchorage-independent growth of KEAP1-mutant cancer cells. Our findings designate NR0B1 as a druggable transcriptional regulator that supports NRF2-dependent lung cancers.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Compounds were discovered that bind a ligandable cysteine on NR0B1, which is regulated by NRF2, a KEAP1 substrate.
“The authors discovered compounds that bind to a ligandable cysteine on the nuclear receptor NR0B1, which is regulated by NRF2, a substrate of KEAP1 (ref.181).”
From Advances in covalent drug discovery (2022) · cites this paper as [181]
Cysteine reactivity and ligandable sites were mapped in mutant KEAP1 and compared with wild-type KEAP1 NSCLC lines.
“cysteine reactivity and ligandable sites were mapped in mutant Kelch-like ECH-associated protein 1 (KEAP1) and compared with those in wild-type KEAP1 NSCLC lines.”
From Advances in covalent drug discovery (2022) · cites this paper as [181]
The authors observed limited overlap of enantioprobe targets with proteins that demonstrated ligandability in previous chemical proteomic studies using cysteine- or lysine-reactive electrophilic fragments.
“We finally observed limited overlap of enantioprobe targets with proteins that demonstrated ligandability in previous chemical proteomic studies using cysteine-26,27 or lysine-reactive28 electrophilic fragments (Fig. 3b)”
From Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs (2019) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · see citing works
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · see citing works
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · see citing works
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · see citing works
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732 · see citing works
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234 · see citing works
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · see citing works
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665 · see citing works
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557 · see citing works
Quantitative reactivity profiling predicts functional cysteines in proteomes
Weerapana, E., Wang, C., Simon, G. M., Richter, F., Khare, S., Dillon, M. B. D., Bachovchin, D. A., Mowen, K., Baker, D., & Cravatt, B. F. (2010) · Nature · doi:10.1038/nature09472 · Cited by 1,684 · see citing works
Self-citationFunctional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683 · see citing works
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 2× · see citing works
“Under conditions of oxidative stress, key cysteines in KEAP1 are oxidatively modified to block interaction with NRF2, stabilizing the transcription factor to allow for nuclear translocation and coordination of a gene expression program that induces detoxification and metabolic enzymes to restore redox homeostasis (Gor…”
Bar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080 · cited 1× · see citing works
“Oligonucleotides See Table S5 N/A N/A Recombinant DNA pLKO.1:shGFP (Bar-Peled et al., 2013) N/A pLKO.1:shNRF2_1 Sigma-Aldrich TRCN0000284998 (Continued on next page) e2 Cell 171, 1–14.e1–e12, October 19, 2017 Please cite this article in press as: Bar-Peled et al., Chemical Proteomics Identifies…”
Self-citationNRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067 · see citing works
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment
Schafer, Z. T., Grassian, A. R., Song, L., Jiang, Z., Gerhart-Hines, Z., Irie, H. Y., Gao, S., Puigserver, P., & Brugge, J. S. (2009) · Nature · doi:10.1038/nature08268 · Cited by 1,031 · see citing works
AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation
Lamia, K. A., Sachdeva, U. M., DiTacchio, L., Williams, E. C., Alvarez, J. G., Egan, D. F., Vasquez, D. S., Juguilon, H., Panda, S., Shaw, R. J., et al. (2009) · Science · doi:10.1126/science.1172156 · Cited by 958 · see citing works
Self-citationProteome-wide covalent ligand discovery in native biological systems
Backus, K. M., Correia, B. E., Lum, K. M., Forli, S., Horning, B. D., González-Páez, G. E., Chatterjee, S., Lanning, B. R., Teijaro, J. R., Olson, A. J., et al. (2016) · Nature · doi:10.1038/nature18002 · Cited by 940 · cited 7× · see citing works
“…http://dx.doi.org/10.1016/j.cell.2017.08.051 of scout fragments found previously to show broad reactivity with cysteines across the human proteome (Backus et al., 2016), we simplified the search for ligandable cysteines in NSCLC lines, and we anticipate that this approach should facilitate the…”
InfluentialSelf-citationYun, J., Mullarky, E., Lu, C., Bosch, K. N., Kavalier, A., Rivera, K., Roper, J., Chio, I. I. C., Giannopoulou, E. G., Rago, C., et al. (2015) · Science · doi:10.1126/science.aaa5004 · Cited by 913 · see citing works
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 801 · see citing works
Developing Irreversible Inhibitors of the Protein Kinase Cysteinome
Liu, Q., Sabnis, Y. A., Zhao, Z., Zhang, T., Buhrlage, S. J., Jones, L. H., & Gray, N. S. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.12.006 · Cited by 662 · see citing works
A comprehensive transcriptional portrait of human cancer cell lines
Klijn, C. N., Durinck, S., Stawiski, E. W., Haverty, P. M., Jiang, Z., Liu, H., Degenhardt, J. D., Mayba, O., Gnad, F., Liu, J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3080 · Cited by 650 · see citing works
Finlay, M. R. V., Anderton, M., Ashton, S., Ballard, P., Bethel, P. A., Box, M. R., Bradbury, R. H., Brown, S. J., Butterworth, S., Campbell, A., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500973a · Cited by 636 · see citing works
Singh, A., Venkannagari, S., Oh, K. H., Zhang, Y., Rohde, J. M., Liu, L., Nimmagadda, S., Sudini, K. R., Brimacombe, K. R., Gajghate, S., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00651 · Cited by 624 · see citing works
Strategies for Discovering and Derisking Covalent, Irreversible Enzyme Inhibitors
Johnson, D. S., Weerapana, E., & Cravatt, B. F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.21 · Cited by 387 · see citing works
Self-citationNRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Chio, I. I. C., Jafarnejad, S. M., Ponz-Sarvise, M., Park, Y., Rivera, K., Palm, W., Wilson, J., Sangar, V., Hao, Y., Öhlund, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.056 · Cited by 378 · cited 2× · see citing works
“A recent cysteine proteomic study performed in Kras-mutated mouse pancreatic cancer organoids deleted for NRF2 expression identified several redox-regulated cysteines (Chio et al., 2016).”
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D.-S., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 315 · see citing works
Cysteine Oxidative Posttranslational Modifications
Chung, H. S., Wang, S.-B., Venkatraman, V., Murray, C. I., & Eyk, J. E. V. (2013) · Circulation Research · doi:10.1161/circresaha.112.268680 · Cited by 297 · see citing works
Weerapana, E., Speers, A. E., & Cravatt, B. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.194 · Cited by 276 · see citing works
Self-citationNox2 redox signaling maintains essential cell populations in the brain
Dickinson, B. C., Peltier, J., Stone, D., Schaffer, D. V., & Chang, C. J. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.497 · Cited by 273 · see citing works
Zinc-Binding Cysteines: Diverse Functions and Structural Motifs
Pace, N., & Weerapana, E. (2014) · Biomolecules · doi:10.3390/biom4020419 · Cited by 241 · see citing works
A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells
Niphakis, M. J., Lum, K. M., Cognetta, A. B., Correia, B. E., Ichu, T.-A., Olucha, J., Brown, S. J., Kundu, S., Piscitelli, F., Rosen, H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.045 · Cited by 239 · see citing works
Self-citationDAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease
Suntharalingham, J. P., Buonocore, F., Duncan, A. J., & Achermann, J. C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.004 · Cited by 233 · see citing works
Site-specific mapping and quantification of protein S-sulphenylation in cells
Yang, J. H., Gupta, V., Carroll, K. S., & Liebler, D. C. (2014) · Nature Communications · doi:10.1038/ncomms5776 · Cited by 232 · see citing works
Multiple roles of cysteine in biocatalysis
Giles, N. M., Giles, G. I., & Jacob, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02770-5 · Cited by 216 · see citing works
High-throughput Phenotyping of Lung Cancer Somatic Mutations
Berger, A. H., Brooks, A. N., Wu, X., Shrestha, Y., Chouinard, C. R., Piccioni, F., Bagul, M., Kamburov, A., Imielinski, M. B., Hogstrom, L. J., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.022 · Cited by 207 · see citing works
Recurrent Loss of NFE2L2 Exon 2 Is a Mechanism for Nrf2 Pathway Activation in Human Cancers
Goldstein, L. D., Lee, J., Gnad, F., Klijn, C. N., Schaub, A., Reeder, J., Daemen, A., Bakalarski, C. E., Holcomb, T., Shames, D. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.010 · Cited by 200 · see citing works
Molecular mechanisms of DAX1 action
Iyer, A. K., & McCabe, E. R. B. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.07.018 · Cited by 193 · see citing works
Thorarensen, A., Dowty, M. E., Banker, M. E., Juba, B., Jussif, J., Lin, T., Vincent, F., Czerwinski, R. M., Casimiro-Garcia, A., Unwalla, R., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01694 · Cited by 176 · see citing works
Self-citationJöst, C., Nitsche, C., Scholz, T., Roux, L., & Klein, C. D. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006918 · Cited by 167 · see citing works
Role of the Keap1–Nrf2 Pathway in Cancer
Leinonen, H. M., Kansanen, E., Pölönen, P., Heinäniemi, M., & Levonen, A. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-420117-0.00008-6 · Cited by 158 · see citing works
Wang, C., Yan, R., Luo, D., Watabe, K., Liao, D., & Cao, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022897 · Cited by 153 · see citing works
Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells
Lee, J., Baek, K., Soetandyo, N., & Ye, Y. (2013) · Nature Communications · doi:10.1038/ncomms2532 · Cited by 147 · see citing works
Zhang, C., Dowd, D. R., Staal, A., Gu, C., Lian, J. B., van Wijnen, A. J., Stein, G. S., & MacDonald, P. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305191200 · Cited by 142 · see citing works
Automated Yeast Two-hybrid Screening for Nuclear Receptor-interacting Proteins
Albers, M., Kranz, H. D., Kober, I., Kaiser, C., Klink, M., SUCKOW, J. M., Kern, R., & Koegl, M. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400169-mcp200 · Cited by 129 · see citing works
Goodwin, J. M., Svensson, R. U., Lou, H. J., Winslow, M. M., Turk, B. E., & Shaw, R. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.021 · Cited by 119 · see citing works
Self-citationGarcía-Aragoncillo, E., Carrillo, J., Lalli, E., Agra, N., Goméz-López, G., Pestaña, Á., & Alonso, J. (2008) · Oncogene · doi:10.1038/onc.2008.203 · Cited by 116 · see citing works
The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1
Sablin, E. P., Woods, A., Krylova, I. N., Hwang, P. K., Ingraham, H. A., & Fletterick, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808936105 · Cited by 106 · see citing works
A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer
Bollong, M. J., Yun, H., Sherwood, L., Woods, A. K., Lairson, L. L., & Schultz, P. G. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00448 · Cited by 98 · see citing works
Planken, S., Behenna, D. C., Nair, S. K., Johnson, T. O., Nagata, A., Almaden, C., Bailey, S., Ballard, T. E., Bernier, L., Cheng, H., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01894 · Cited by 97 · see citing works
Kinsey, M., Smith, R. A., Iyer, A. K., McCabe, E. R. B., & Lessnick, S. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1540 · Cited by 95 · see citing works
Cardoso, R., Love, R., Nilsson, C. L., Bergqvist, S., Nowlin, D., Yan, J., Liu, K. K. ‐., Zhu, J., Chen, P., Deng, Y., et al. (2012) · Protein Science · doi:10.1002/pro.2172 · Cited by 79 · see citing works
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events
Ashouri, A., Sayin, V. I., den Eynden, J. V., Singh, S. X., Papagiannakopoulos, T. Y., & Larsson, E. (2016) · Nature Communications · doi:10.1038/ncomms13197 · Cited by 65 · see citing works
Komashko, V., Acevedo, L. G., Squazzo, S. L., Iyengar, S., Rabinovich, A., O’Geen, H., Green, R., & Farnham, P. (2008) · Genome Research · doi:10.1101/gr.074609.107 · Cited by 56 · see citing works
E3 Ubiquitin Ligase RNF31 Cooperates with DAX-1 in Transcriptional Repression of Steroidogenesis
Ehrlund, A., Anthonisen, E. H., Gustafsson, N., Venteclef, N., Remen, K. M. R., Damdimopoulos, A. E., Galeeva, A., Pelto‐Huikko, M., Lalli, E., Steffensen, K. R., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00743-08 · Cited by 50 · see citing works
Tumorigenic Role of Orphan Nuclear Receptor NR0B1 in Lung Adenocarcinoma
Oda, T., Tian, T., Inoue, M., Ikeda, J., Qiu, Y., Okumura, M., Aozasa, K., & Morii, E. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090010 · Cited by 37 · see citing works
Bruton's tyrosine kinase as a drug discovery target
Pan, Z. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.7.1255308 · Cited by 30 · see citing works
Rostovtsev, V. V., Green, L. G., Fokin, V. V., & Sharpless, K. B. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020715)41:14
Flagged first, then by citations
Cited by
Sorted by citations
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968 · see citing works
Cancer metabolism: looking forward
Martínez‐Reyes, I., & Chandel, N. S. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,852 · see citing works
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,474 · see citing works
The molecular landscape of head and neck cancer
Leemans, C. R., Snijders, P. J. F., & Brakenhoff, R. H. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2018.11 · Cited by 1,414 · see citing works
Advances in covalent drug discovery
Boike, L., Henning, N. J., & Nomura, D. K. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00542-z · Cited by 823 · see citing works
Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation
Lü, Y., Li, Z., Zhang, S., Zhang, T., Liu, Y., & Zhang, L. (2023) · Theranostics · doi:10.7150/thno.79876 · Cited by 717 · see citing works
The Complex Interplay between Antioxidants and ROS in Cancer
Harris, I. S., & DeNicola, G. M. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.03.002 · Cited by 638 · see citing works
Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles
Eaton, J. K., Furst, L., Ruberto, R. A., Moosmayer, D., Hilpmann, A., Ryan, M. J., Zimmermann, K. C., Cai, L. L., Niehues, M., Badock, V., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0501-5 · Cited by 510 · see citing works
Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
Zhang, X., Crowley, V. M., Wucherpfennig, T. G., Dix, M. M., & Cravatt, B. F. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0279-5 · Cited by 487 · see citing works
Self-citationZhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442 · see citing works
Click Chemistry in Proteomic Investigations
Parker, C. G., & Pratt, M. R. (2020) · Cell · doi:10.1016/j.cell.2020.01.025 · Cited by 386 · see citing works
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells
Vinogradova, E. V., Zhang, X., Remillard, D., Lazar, D. C., Suciu, R. M., Wang, Y., Bianco, G., Yamashita, Y., Crowley, V. M., Schafroth, M. A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.001 · Cited by 351 · see citing works
Self-citationRedox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 357 · see citing works
Kuljanin, M., Mitchell, D. C., Schweppe, D. K., Gikandi, A. S., Nusinow, D. P., Bulloch, N. J., Vinogradova, E. V., Wilson, D. L., Kool, E. T., Mancias, J. D., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00778-3 · Cited by 305 · see citing works
Self-citationNRF2 as a regulator of cell metabolism and inflammation in cancer
He, F., Antonucci, L., & Karin, M. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa039 · Cited by 318 · see citing works
Galan-Cobo, A., Sitthideatphaiboon, P., Qu, X., Poteete, A., Pisegna, M. A., Tong, P., Chen, P.-H., Boroughs, L. K., Rodriguez, M. L. M., Zhang, W., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3527 · Cited by 292 · see citing works
Proteome-wide analysis of cysteine oxidation reveals metabolic sensitivity to redox stress
van der Reest, J., Lilla, S., Zheng, L., Zanivan, S. R., & Gottlieb, E. (2018) · Nature Communications · doi:10.1038/s41467-018-04003-3 · Cited by 267 · see citing works
Chen, X., Wang, Y., Ma, N., Tian, J., Shao, Y., Zhu, B., Wong, Y. K., Liang, Z., Zou, C., & Wang, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0186-y · Cited by 274 · see citing works
A proteome-wide atlas of lysine-reactive chemistry
Abbasov, M. E., Kavanagh, M. E., Ichu, T.-A., Lazear, M. R., Tao, Y., Crowley, V. M., Ende, C. W. A., Hacker, S. M., Ho, J. S., Dix, M. M., et al. (2021) · Nature Chemistry · doi:10.1038/s41557-021-00765-4 · Cited by 242 · see citing works
Self-citationMachine learning of serum metabolic patterns encodes early-stage lung adenocarcinoma
Huang, L., Wang, L., Hu, X., Chen, S., Tao, P., Su, H., Yang, J., Xu, W. L., Vedarethinam, V., Wu, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17347-6 · Cited by 238 · see citing works
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Hillebrand, L., Liang, X. J., Serafim, R. A. M., & Gehringer, M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01825 · Cited by 212 · see citing works
DCAF11 Supports Targeted Protein Degradation by Electrophilic Proteolysis-Targeting Chimeras
Zhang, X., Luukkonen, L. M., Eissler, C. L., Crowley, V. M., Yamashita, Y., Schafroth, M. A., Kikuchi, S., Weinstein, D. S., Symons, K. T., Nordin, B. E., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c00990 · Cited by 199 · see citing works
Self-citationThe pleiotropic functions of reactive oxygen species in cancer
Wu, K., Zowalaty, A. E. E., Sayin, V. I., & Papagiannakopoulos, T. Y. (2024) · Nature Cancer · doi:10.1038/s43018-024-00738-9 · Cited by 203 · see citing works
NRF2 Activation in Cancer: From DNA to Protein
Cloer, E. W., Goldfarb, D., Schrank, T. P., Weissman, B. E., & Major, M. B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2723 · Cited by 182 · see citing works
Principles and functions of metabolic compartmentalization
Bar-Peled, L., & Kory, N. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00645-2 · Cited by 157 · see citing works
Self-citationThe gut microbiota reprograms intestinal lipid metabolism through long noncoding RNA Snhg9
Wang, Y., Wang, M., Chen, J., Li, Y., Kuang, Z., Dende, C., Raj, P., Quinn, G. M., Hu, Z., Srinivasan, T., et al. (2023) · Science · doi:10.1126/science.ade0522 · Cited by 186 · see citing works
Reactive-cysteine profiling for drug discovery
Maurais, A. J., & Weerapana, E. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.02.010 · Cited by 167 · see citing works
Regulation of redox balance in cancer and T cells
Kong, H., & Chandel, N. S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000257 · Cited by 180 · see citing works
Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs
Wang, Y., Dix, M. M., Bianco, G., Remsberg, J. R., Lee, H.-Y., Kalocsay, M., Gygi, S. P., Forli, S., Vite, G., Lawrence, R. M., et al. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0351-5 · Cited by 179 · see citing works
Self-citationReimagining Druggability Using Chemoproteomic Platforms
Spradlin, J. N., Zhang, E., & Nomura, D. K. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00065 · Cited by 176 · see citing works
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion
Harris, I. S., Endress, J. E., Coloff, J. L., Selfors, L. M., McBrayer, S. K., Rosenbluth, J. M., Takahashi, N., Dhakal, S., Koduri, V., Oser, M. G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.020 · Cited by 168 · see citing works
Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
Kreuzaler, P. A., Panina, Y., Segal, J., & Yuneva, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.021 · Cited by 151 · see citing works
Targeting Metabolic–Redox Circuits for Cancer Therapy
Wang, K., Jiang, J., Lei, Y., Zhou, S., Wei, Y., & Huang, C. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2019.01.001 · Cited by 162 · see citing works
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer
Weiss‐Sadan, T., Ge, M., Hayashi, M., Gohar, M., Yao, C.-H., de Groot, A., Harry, S. A., Carlin, A. D., Fischer, H., Shi, L., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.012 · Cited by 156 · see citing works
Self-citationThe role of reversible and irreversible covalent chemistry in targeted protein degradation
Kiely‐Collins, H., Winter, G. E., & Bernardes, G. J. L. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.03.005 · Cited by 156 · see citing works
Zhang, J., Simpson, C. M., Berner, J., Chong, H. B., Fang, J., Ordulu, Z., Weiss‐Sadan, T., Possemato, A. P., Harry, S. A., Takahashi, M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.04.026 · Cited by 146 · see citing works
Self-citationA catalogue of somatic NRF2 gain-of-function mutations in cancer
Kerins, M. J., & Ooi, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-31281-0 · Cited by 140 · see citing works
Chemoproteomics and Chemical Probes for Target Discovery
Drewes, G., & Knapp, S. (2018) · Trends in Biotechnology · doi:10.1016/j.tibtech.2018.06.008 · Cited by 132 · see citing works
Fragment-based covalent ligand discovery
Lu, W., Kostic, M., Zhang, T., Che, J., Patricelli, M. P., Jones, L. H., Chouchani, E. T., & Gray, N. S. (2021) · RSC Chemical Biology · doi:10.1039/d0cb00222d · Cited by 136 · see citing works
Ligandability of E3 Ligases for Targeted Protein Degradation Applications
Belcher, B. P., Ward, C. C., & Nomura, D. K. (2023) · Biochemistry · doi:10.1021/acs.biochem.1c00464 · Cited by 132 · see citing works
Tao, Y., Remillard, D., Vinogradova, E. V., Yokoyama, M., Banchenko, S., Schwefel, D., Melillo, B. N., Schreiber, S. L., Zhang, X., & Cravatt, B. F. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c08964 · Cited by 125 · see citing works
Self-citationTunable Heteroaromatic Sulfones Enhance in-Cell Cysteine Profiling
Motiwala, H. F., Kuo, Y.-H., Stinger, B. L., Palfey, B. A., & Martin, B. R. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b08831 · Cited by 125 · see citing works
A chemoproteomic portrait of the oncometabolite fumarate
Kulkarni, R. A., Bak, D. W., Wei, D., Bergholtz, S. E., Briney, C. A., Shrimp, J. H., Alpsoy, A., Thorpe, A. L., Bavari, A. E., Crooks, D. R., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0217-y · Cited by 121 · see citing works
Metabolic Regulation of Redox Balance in Cancer
Purohit, V., Simeone, D. M., & Lyssiotis, C. A. (2019) · Cancers · doi:10.3390/cancers11070955 · Cited by 115 · see citing works
He, F., Antonucci, L., Yamachika, S., Zhang, Z., Taniguchi, K., Umemura, A., Hatzivassiliou, G., Roose‐Girma, M., Reina‐Campos, M., Durán, Á., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.023 · Cited by 108 · see citing works
Machine learning and AI-based approaches for bioactive ligand discovery and GPCR-ligand recognition
Raschka, S., & Kaufman, B. (2020) · Methods · doi:10.1016/j.ymeth.2020.06.016 · Cited by 110 · see citing works
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
Takahashi, M., Chong, H. B., Zhang, S., Yang, T.-Y., Lazarov, M. J., Harry, S. A., Maynard, M., Hilbert, B. J., White, R. D., Murrey, H. E., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.027 · Cited by 107 · see citing works
Self-citationBioSITe: A Method for Direct Detection and Quantitation of Site-Specific Biotinylation
Kim, D. I., Cutler, J. A., Na, C. H., Reckel, S., Renuse, S., Madugundu, A. K., Tahir, R., Goldschmidt, H. L., Reddy, K. L., Huganir, R. L., et al. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00775 · Cited by 101 · see citing works
Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies
Santarpía, M., Aguilar, A., CHAIB-OUKADOUR, I., Cardona, A. F., Fancelli, S., Laguía, F., Bracht, J. W. P., Cao, P., Molina‐Vila, M. Á., Karachaliou, N., et al. (2020) · Cancers · doi:10.3390/cancers12061475 · Cited by 100 · see citing works
Tunable Methacrylamides for Covalent Ligand Directed Release Chemistry
Reddi, R. N., Resnick, E., Rogel, A., Rao, B. V., Gabizon, R., Goldenberg, K., Gurwicz, N., Zaidman, D., Plotnikov, A. N., Barr, H. M., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c10644 · Cited by 99 · see citing works
CysDB: a human cysteine database based on experimental quantitative chemoproteomics
Boatner, L. M., Palafox, M. F., Schweppe, D. K., & Backus, K. M. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.04.004 · Cited by 97 · see citing works
Self-citationEnhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers
Okazaki, K., Anzawa, H., Liu, Z., Ota, N., Kitamura, H., Onodera, Y., Alam, M. M., Matsumaru, D., Suzuki, T., Katsuoka, F., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19593-0 · Cited by 97 · see citing works
Redox regulation of macrophages
Tran, N., & Mills, E. L. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103123 · Cited by 97 · see citing works
A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification
Browne, C. M., Jiang, B., Ficarro, S. B., Doctor, Z. M., Johnson, J. L., Card, J. D., Sivakumaren, S. C., Alexander, W. M., Yaron, T. M., Murphy, C. J., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b07911 · Cited by 90 · see citing works
SP3‐FAIMS Chemoproteomics for High‐Coverage Profiling of the Human Cysteinome**
Yan, T., Desai, H. S., Boatner, L. M., Yen, S. L., Cao, J. X., Palafox, M. F., Jami‐Alahmadi, Y., & Backus, K. M. (2021) · ChemBioChem · doi:10.1002/cbic.202000870 · Cited by 90 · see citing works
Self-citationProteomic discovery of chemical probes that perturb protein complexes in human cells
Lazear, M. R., Remsberg, J. R., Jaeger, M. G., Rothamel, K. L., Her, H.-L., DeMeester, K. E., Njomen, E., Hogg, S. J., Rahman, J. A., Whitby, L. R., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.03.026 · Cited by 84 · see citing works
Self-citationMetabolic regulation of somatic stem cells in vivo
Meacham, C. E., DeVilbiss, A. W., & Morrison, S. J. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00462-1 · Cited by 85 · see citing works
Ligand discovery by activity-based protein profiling
Niphakis, M. J., & Cravatt, B. F. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.08.006 · Cited by 90 · see citing works
Self-citationFu, L., Li, Z., Liu, K., Tian, C., He, J.-X., He, J., He, F., Xu, P., & Yang, J. H. (2020) · Nature Protocols · doi:10.1038/s41596-020-0352-2 · Cited by 84 · see citing works
Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine
Kavanagh, M. E., Horning, B. D., Khattri, R., Roy, N., Lu, J. P., Whitby, L. R., Ye, E., Brannon, J. C., Parker, A., Chick, J. M., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01098-0 · Cited by 82 · see citing works
Self-citationSelective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain
Feldman, H. C., Merlini, E., Guijas, C., DeMeester, K. E., Njomen, E., Kozina, E. M., Yokoyama, M., Vinogradova, E. V., Reardon, H. T., Melillo, B. N., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208457119 · Cited by 79 · see citing works
Self-citationHigh‐Throughput Kinetic Analysis for Target‐Directed Covalent Ligand Discovery
Craven, G. B., Affron, D. P., Allen, C. E., Matthies, S., Greener, J. G., Morgan, R. M. L., Tate, E. W., Armstrong, A., & Mann, D. J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201711825 · Cited by 73 · see citing works
Schreiber, S. L. (2018) · Israel Journal of Chemistry · doi:10.1002/ijch.201800113 · Cited by 76 · see citing works
Redox Systems Biology: Harnessing the Sentinels of the Cysteine Redoxome
Held, J. M. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7725 · Cited by 73 · see citing works
Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
Romero, R., Rivera, F. J. S., Westcott, P. M. K., Mercer, K. L., Bhutkar, A. J., Muir, A., González-Robles, T. J., Rodríguez, S. L., Liao, L. Z., Ng, S. R., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0071-1 · Cited by 75 · see citing works
Xu, K., Ma, J., Hall, S. R. R., Peng, R., Yang, H., & Yao, F. (2023) · Theranostics · doi:10.7150/thno.80184 · Cited by 75 · see citing works
Cysteine-reactive probes and their use in chemical proteomics
Hoch, D. G., Abegg, D., & Adibekian, A. (2018) · Chemical Communications · doi:10.1039/c8cc01485j · Cited by 74 · see citing works
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tamura, T., Kawano, M., & Hamachi, I. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00745 · Cited by 71 · see citing works
Nrf2 Mediates Metabolic Reprogramming in Non-Small Cell Lung Cancer
Zhao, J., Xu, L., Meng, D., Zeng, L., Zhuang, R., Huang, S., Lv, W., & Hu, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.578315 · Cited by 70 · see citing works
The rise of covalent proteolysis targeting chimeras
Gabizon, R., & London, N. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.12.003 · Cited by 70 · see citing works
NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
Guo, H., Xu, J., Zheng, Q., He, J.-L., Zhou, W., Wang, K., Huang, X., Fan, Q.-J., Ma, J., Cheng, J.-K., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.010 · Cited by 70 · see citing works
Spatial and temporal alterations in protein structure by EGF regulate cryptic cysteine oxidation
Behring, J. B., van der Post, S., Mooradian, A. D., Egan, M. J., Zimmerman, M. I., Clements, J. L., Bowman, G. R., & Held, J. M. (2020) · Science Signaling · doi:10.1126/scisignal.aay7315 · Cited by 69 · see citing works
Fuloria, S., Subramaniyan, V., Sundram, K., Kumari, U., Sathasivam, K. V., Meenakshi, D. U., Wu, Y. S., Sekar, M., Chitranshi, N., Malviya, R., et al. (2021) · Antioxidants · doi:10.3390/antiox10010128 · Cited by 73 · see citing works
The Pleiotropic Role of the KEAP1/NRF2 Pathway in Cancer
Wu, W., & Papagiannakopoulos, T. Y. (2020) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055627 · Cited by 68 · see citing works
Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides
Li, F., Fu, V. X., Liu, G., Tang, T. T.-L., Konradi, A. W., Peng, X., Kemper, E. K., Cravatt, B. F., Franklin, J. M., Wu, Z., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01061-z · Cited by 63 · see citing works
Self-citationAssigning functionality to cysteines by base editing of cancer dependency genes
Li, H., Ma, T., Remsberg, J. R., Won, S. J., DeMeester, K. E., Njomen, E., Ogasawara, D., Zhao, K. T., Huang, T. P., Lu, B., et al. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01428-w · Cited by 62 · see citing works
Self-citationMachine learning for target discovery in drug development
Rodrigues, T., & Bernardes, G. J. L. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.003 · Cited by 60 · see citing works
Global profiling of phosphorylation-dependent changes in cysteine reactivity
Kemper, E. K., Zhang, Y., Dix, M. M., & Cravatt, B. F. (2022) · Nature Methods · doi:10.1038/s41592-022-01398-2 · Cited by 60 · see citing works
Self-citationTMEM164 is an acyltransferase that forms ferroptotic C20:4 ether phospholipids
Reed, A., Ware, T. B., Li, H., Bazán, J. F., & Cravatt, B. F. (2023) · Nature Chemical Biology · doi:10.1038/s41589-022-01253-7 · Cited by 62 · see citing works
Self-citationThe Proteome‐Wide Potential for Reversible Covalency at Cysteine
Senkane, K., Vinogradova, E. V., Suciu, R. M., Crowley, V. M., Zaro, B. W., Bradshaw, J. M., Brameld, K. A., & Cravatt, B. F. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201905829 · Cited by 57 · see citing works
Self-citationMulti-tiered chemical proteomic maps of tryptoline acrylamide–protein interactions in cancer cells
Njomen, E., Hayward, R. E., DeMeester, K. E., Ogasawara, D., Dix, M. M., Nguyen, T., Ashby, P., Simon, G. M., Schreiber, S. L., Melillo, B. N., et al. (2024) · Nature Chemistry · doi:10.1038/s41557-024-01601-1 · Cited by 65 · see citing works
Self-citationFunctionalized Scout Fragments for Site-Specific Covalent Ligand Discovery and Optimization
Crowley, V. M., Thielert, M., & Cravatt, B. F. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01336 · Cited by 53 · see citing works
Self-citationTargeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target
Ma, S., Paiboonrungruan, C., Yan, T., Williams, K. P., Major, M. B., & Chen, X. L. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13681 · Cited by 54 · see citing works
Metabolic determinants of cellular fitness dependent on mitochondrial reactive oxygen species
Kong, H., Reczek, C. R., McElroy, G. S., Steinert, E. M., Wang, T., Sabatini, D. M., & Chandel, N. S. (2020) · Science Advances · doi:10.1126/sciadv.abb7272 · Cited by 53 · see citing works
How the Local Environment of Functional Sites Regulates Protein Function
Mazmanian, K., Sargsyan, K., & Lim, C. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c02430 · Cited by 50 · see citing works
Reductive stress in cancer: coming out of the shadows
Ge, M., Papagiannakopoulos, T. Y., & Bar‐Peled, L. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.10.002 · Cited by 50 · see citing works
Self-citationWhite, M. E. H., Gil, J., & Tate, E. W. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.06.021 · Cited by 48 · see citing works
Redirecting the pioneering function of FOXA1 with covalent small molecules
Won, S. J., Zhang, Y., Reinhardt, C. J., Hargis, L. M., MacRae, N. S., DeMeester, K. E., Njomen, E., Remsberg, J. R., Melillo, B. N., Cravatt, B. F., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.09.024 · Cited by 45 · see citing works
Self-citationTarget Identification of Bioactive Covalently Acting Natural Products
Nomura, D. K., & Maimone, T. J. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_121 · Cited by 43 · see citing works
Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
Panda, H., Wen, H., Suzuki, M., & Yamamoto, M. P. (2022) · Antioxidants · doi:10.3390/antiox11030538 · Cited by 44 · see citing works
Covalent binders in drug discovery
Vasudevan, A., Argiriadi, M. A., Baranczak, A., Friedman, M., Gavrilyuk, J. I., Hobson, A. D., Hulce, J. J., Osman, S., & Wilson, N. S. (2019) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2018.12.002 · Cited by 42 · see citing works
Tallon, A. M., Xu, Y., West, G. M., am Ende, C. W., & Fox, J. M. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c04444 · Cited by 43 · see citing works
Applications of Reactive Cysteine Profiling
Backus, K. M. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_120 · Cited by 38 · see citing works
Self-citationIdentification and selectivity profiling of small-molecule degraders via multi-omics approaches
Scholes, N. S., Mayor‐Ruiz, C., & Winter, G. E. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.03.007 · Cited by 41 · see citing works
The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
Occhiuto, C. J., Moerland, J. A., Leal, A. S., Gallo, K. A., & Liby, K. T. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2191 · Cited by 40 · see citing works
Liu, Y., Lv, S., Peng, L., Xie, C., Gao, L., Sun, H., Lin, L., Ding, K., & Li, Z. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114636 · Cited by 40 · see citing works
Torrente, L., Maan, G., Rezig, A. O. M., Quinn, J. A., Jackson, A. W., Grilli, A., Casares, L., Zhang, Y., Kulesskiy, E., Saarela, J., et al. (2020) · Biomolecules · doi:10.3390/biom10101365 · Cited by 40 · see citing works
Yan, T., Julio, A., Villanueva, M., Jones, A. E., Ball, A. B., Boatner, L. M., Turmon, A. C., Nguyễn, K. B., Yen, S. L., Desai, H., et al. (2023) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.06.008 · Cited by 18 · see citing works
Self-citationLondon, N. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00570 · Cited by 36 · see citing works
Oxidation of retromer complex controls mitochondrial translation
Zhang, J., Ali, M. Y., Chong, H. B., Tien, P.-C., Woods, J., Noble, C., Vornbäumen, T., Ordulu, Z., Possemato, A. P., Harry, S. A., et al. (2025) · Nature · doi:10.1038/s41586-025-08756-y · Cited by 38 · see citing works
Self-citation
- Authors
- Bar-Peled, L., Kemper, E. K., Suciu, R. M., Vinogradova, E. V., Backus, K. M., Horning, B. D., Paul, T. A., Ichu, T.-A., Svensson, R. U., Olucha, J., Chang, M. W., Kok, B. P., Zhu, Z., Ihle, N. T., Dix, M. M., Jiang, P., Hayward, M. M., Saez, E., Shaw, R. J., & Cravatt, B. F.
- Affiliations
- Scripps Research Institute (US)
- Pfizer (United States) (US)
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Corresponding author
- Cravatt, Benjamin F.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 171
- Issue
- 3
- Pages
- 696-709.e23
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5728659
- OpenAlex
- W2757007104
- Cited by
- 262
- References
- 59
- Citations by year
- 2026: 12 · 2025: 28 · 2024: 34 · 2023: 41 · 2022: 29 · 2021: 30 · 2020: 25 · 2019: 36 · 2018: 24 · 2017: 3
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (CA087660, CA132630, CA172229, CA215249-01, CA211526)
- NIH-NCI CCSG (P30 014195)
- Chapman Foundation
- Helmsley Charitable Trust
- Damon Runyon Cancer Research Foundation
- American Cancer Society
- Life Sciences Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Treatments and Mutations
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- Nrf2, KEAP1 mutation, non-small cell lung cancer, NR0B1, orphan nuclear receptor, chemoproteomics, druggable vulnerabilities, covalent inhibitors, anchorage-independent growth, transcriptional regulation, antioxidant response
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Carcinoma, Non-Small-Cell Lung, Cysteine, Humans, Ligands, Lung Neoplasms, Proteome, Cell Line, Tumor, Gene Regulatory Networks, DAX-1 Orphan Nuclear Receptor, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
